Trials / Completed
CompletedNCT04330755
Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy
The Effect of Levosimendan Versus Its Combination to Magnesium Sulphate on Spinal Cord Protection Guided by NIRS in Infants Undergoing Coarctectomy: A Randomized Controlled Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Dalia Saad Abd-El Kader · Academic / Other
- Sex
- All
- Age
- 1 Day – 12 Months
- Healthy volunteers
- Not accepted
Summary
In pediatric patients ,undergoing elective surgical correction of aortic coarcatation one of our main concern is spinal cord protection .Our aim to study the protective effect of levosimendan versus its combination with magnesium sulphate .
Detailed description
Effect of levosimendan and its combination with magnesium sulphate infusion as spinal cord protection using NIRS values before Aortic cross clamp and 10,20 min after cross clamp till the end of surgery .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saline Solution | Placebo |
| DRUG | Levosimendan | Levosimendan |
| DRUG | Magnesium Sulfate | Magnesium Sulfate |
Timeline
- Start date
- 2021-02-04
- Primary completion
- 2023-03-30
- Completion
- 2023-04-30
- First posted
- 2020-04-01
- Last updated
- 2023-10-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04330755. Inclusion in this directory is not an endorsement.